Cullinan Therapeutics (CGEM)
Develops bispecific T-cell engagers for autoimmune disease and cancer through a hub-and-spoke drug-development model.
$21.67
After hours0.00 (0.00%)
At close$21.67(+1.50%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
estimated · in 44 days
EPS estimate
−$0.84
Revenue estimate
$2.0M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.73−$0.74−$1.07−$0.77−$0.77−$0.75−$0.81Pending
Estimate−$0.75−$0.78−$0.83−$0.95−$0.80−$0.84−$0.80−$0.84
Surprise+2.7%+5.1%−28.9%+18.9%+3.8%+10.3%−1.3%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate———$5.6M$5.0M$3.7M$3.7M$2.0M
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.98 | — | — |
| Sep 2028 | −$0.85 | — | — |
| Jun 2028 | −$0.82 | — | — |
| Mar 2028 | $0.32 | — | — |
| Dec 2027 | −$0.64 | — | — |
| Sep 2027 | −$0.87 | — | — |
| Jun 2027 | −$0.82 | — | — |
| Mar 2027 | −$0.64 | — | — |
| Dec 2026 | −$0.72 | — | — |
| Nov 2026 | −$0.84 | — | — |
| Aug 2026 | −$0.80 | −$0.81 | −1.3% |
| May 2026 | −$0.84 | −$0.75 | +10.3% |
| Mar 2026 | −$0.80 | −$0.77 | +3.8% |
| Nov 2025 | −$0.95 | −$0.77 | +18.9% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Jan 2021 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.98 | — | — | $0 | — | — | — |
| Sep 2028 | −$0.85 | — | — | $0 | — | — | — |
| Jun 2028 | −$0.82 | — | — | $0 | — | — | — |
| Mar 2028 | $0.32 | — | — | $0 | — | — | — |
| Dec 2027 | −$0.64 | — | — | $36.6M | — | — | — |
| Sep 2027 | −$0.87 | — | — | $4.0M | — | — | — |
| Jun 2027 | −$0.82 | — | — | $2.1M | — | — | — |
| Mar 2027 | −$0.64 | — | — | $10.0M | — | — | — |
| Dec 2026 | −$0.72 | — | — | $13.0M | — | — | — |
| Nov 5, 2026 | −$0.84 | — | — | $2.0M | — | — | — |
| Aug 6, 2026 | −$0.80 | −$0.81 | −1.3% | $3.7M | — | — | +1.9% |
| May 7, 2026 | −$0.84 | −$0.75 | +10.3% | $3.7M | — | — | −1.8% |
| Mar 10, 2026 | −$0.80 | −$0.77 | +3.8% | $5.0M | — | — | −2.6% |
| Nov 6, 2025 | −$0.95 | −$0.77 | +18.9% | $5.6M | — | — | +0.6% |
| Aug 7, 2025 | |||||||
| May 8, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 15, 2024 | |||||||
| Mar 14, 2024 | |||||||
| Nov 8, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 9, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 10, 2022 | |||||||
| May 16, 2022 | |||||||
| Mar 17, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 10, 2021 | |||||||
| May 14, 2021 | |||||||
| Mar 30, 2021 | |||||||
| Jan 6, 2021 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 |